First Turn Management »

Natera shares owned by First Turn Management

Quarter-by-quarter ownership of Natera (NTRA) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Natera

Tip: Access up to 7 years of quarterly data

All positions including Natera held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Natera by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $20M 156k 126.95

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Natera

Vanguard Group
BlackRock
BlackRock
Fred Alger Management
Jpmorgan Chase & Co
Farallon Capital Management
State Street Corporation
Citadel Advisors
Massachusetts Financial Services
Invesco
Geode Capital Management
Kynam Capital Management
Duquesne Family Office
Lord, Abbett & Co
Alliancebernstein

View all funds holding Natera